K123733 is an FDA 510(k) clearance for the CARDIOBLATE CRYOFLEX SURGICAL ABLATION SYSTEM. This device is classified as a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II - Special Controls, product code OCL).
Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on April 1, 2013, 117 days after receiving the submission on December 5, 2012.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 878.4400. Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue.